Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Middlesex Water
MSEX
$1.1B
| $15.2M | ﹤0.01% |
239,166
+6,740
| +3% | +$427K |
|
1727
Greif
GEF
$5B
| $15.2M | ﹤0.01% |
343,372
+18,097
| +6% | +$749K |
|
1728
Cardlytics
CDLX
$24.7M
| $15.2M | ﹤0.01% |
24,114
+2,964
| +14% | +$1.45M |
|
|
CVET
1729
DELISTED
Covetrus, Inc. Common Stock
CVET
| $15.1M | ﹤0.01% |
1,145,276
+32,045
| +3% | +$388K |
|
1730
Denali Therapeutics
DNLI
$4.04B
| $15.1M | ﹤0.01% |
867,618
+24,847
| +3% | +$414K |
|
1731
B&G Foods
BGS
$291M
| $15.1M | ﹤0.01% |
841,784
-166,109
| -16% | -$2.79M |
|
1732
Mercury Insurance
MCY
$5.84B
| $15.1M | ﹤0.01% |
309,319
+10,919
| +4% | +$549K |
|
1733
Kulicke & Soffa
KLIC
$4.98B
| $15M | ﹤0.01% |
552,081
-3,561
| -0.6% | -$87.8K |
|
1734
Green Dot
GDOT
$766M
| $15M | ﹤0.01% |
643,942
+7,743
| +1% | +$193K |
|
1735
Enova International
ENVA
$6.48B
| $15M | ﹤0.01% |
622,961
+2,273
| +0.4% | +$51.2K |
|
1736
Acushnet Holdings
GOLF
$5.2B
| $15M | ﹤0.01% |
460,509
+16,673
| +4% | +$495K |
|
|
ENDP
1737
DELISTED
Endo International plc
ENDP
| $15M | ﹤0.01% |
3,189,469
+49,430
| +2% | +$221K |
|
|
MRC
1738
DELISTED
MRC Global
MRC
| $15M | ﹤0.01% |
1,096,462
+15,319
| +1% | +$200K |
|
1739
Cenovus Energy
CVE
$55.6B
| $14.9M | ﹤0.01% |
1,473,601
+186,325
| +14% | +$1.69M |
|
|
PRNB
1740
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $14.8M | ﹤0.01% |
270,786
+123,977
| +84% | +$4.63M |
|
|
EBSB
1741
DELISTED
Meridian Bancorp, Inc.
EBSB
| $14.8M | ﹤0.01% |
737,022
+19,448
| +3% | +$381K |
|
|
FTSV
1742
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $14.8M | ﹤0.01% |
375,503
+94,704
| +34% | +$1.52M |
|
|
CLDT
1743
Chatham Lodging
CLDT
$590M
| $14.8M | ﹤0.01% |
805,989
+46,635
| +6% | +$841K |
|
1744
Heartland Express
HTLD
$950M
| $14.8M | ﹤0.01% |
700,788
-3,320
| -0.5% | -$71.2K |
|
1745
The RMR Group
RMR
$337M
| $14.7M | ﹤0.01% |
322,826
+9,642
| +3% | +$447K |
|
|
QEP
1746
DELISTED
QEP RESOURCES, INC.
QEP
| $14.7M | ﹤0.01% |
3,271,449
+196,393
| +6% | +$684K |
|
|
PS
1747
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $14.7M | ﹤0.01% |
854,303
+49,821
| +6% | +$848K |
|
|
HEES
1748
DELISTED
H&E Equipment Services
HEES
| $14.6M | ﹤0.01% |
435,820
+1,982
| +0.5% | +$64.3K |
|
|
TIVO
1749
DELISTED
Tivo Inc
TIVO
| $14.6M | ﹤0.01% |
1,716,380
-28,369
| -2% | -$224K |
|
|
BPFH
1750
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $14.5M | ﹤0.01% |
1,208,868
+38,510
| +3% | +$446K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.